STRYKER CORP Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year
STRYKER CORP (SYK) had Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year of $351.00 million as of 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear · last filed 2026-07-31
- 2026-06-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $351.00M.
- 2026-03-31: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $557.00M.
- 2025-09-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $190.00M.
- 2025-06-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $374.00M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year |
|---|---|
| 2026-06-30 | $351.00M 10-Q · filed 2026-07-31 |
| 2026-03-31 | $557.00M 10-Q · filed 2026-05-11 |
| 2025-09-30 | $190.00M 10-Q · filed 2025-10-31 |
| 2025-06-30 | $374.00M 10-Q · filed 2025-08-01 |
| 2025-03-31 | $561.00M 10-Q · filed 2025-05-02 |
| 2024-09-30 | $169.00M 10-Q · filed 2024-10-30 |
| 2024-06-30 | $312.00M 10-Q · filed 2024-07-31 |
| 2024-03-31 | $468.00M 10-Q · filed 2024-05-01 |
| 2023-09-30 | $159.00M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $319.00M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $463.00M 10-Q · filed 2023-05-02 |
| 2022-09-30 | $159.00M 10-Q · filed 2022-11-01 |
| 2022-06-30 | $320.00M 10-Q · filed 2022-07-27 |
| 2022-03-31 | $484.00M 10-Q · filed 2022-04-29 |
| 2021-09-30 | $149.00M 10-Q · filed 2021-10-29 |
| 2021-06-30 | $300.00M 10-Q · filed 2021-07-28 |
| 2021-03-31 | $450.00M 10-Q · filed 2021-04-28 |
| 2020-09-30 | $115.00M 10-Q · filed 2020-10-30 |
| 2020-06-30 | $230.00M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $341.00M 10-Q · filed 2020-05-01 |
| 2019-12-31 | $457.00M 10-K · filed 2020-02-06 |
| 2019-09-30 | $114.00M 10-Q · filed 2019-10-30 |
| 2019-06-30 | $230.00M 10-Q · filed 2019-07-26 |
| 2019-03-31 | $333.00M 10-Q · filed 2019-04-24 |
| 2018-12-31 | $438.00M 10-K · filed 2019-02-07 |
| 2018-09-30 | $105.00M 10-Q · filed 2018-10-26 |
| 2018-06-30 | $198.00M 10-Q · filed 2018-07-25 |
| 2018-03-31 | $287.00M 10-Q · filed 2018-04-27 |
| 2017-12-31 | $368.00M 10-K · filed 2018-02-08 |
| 2017-09-30 | $90.00M 10-Q · filed 2017-10-27 |
| 2017-06-30 | $177.00M 10-Q · filed 2017-07-28 |
| 2017-03-31 | $258.00M 10-Q · filed 2017-04-27 |
| 2016-12-31 | $345.00M 10-K · filed 2017-02-09 |
| 2016-09-30 | $86.00M 10-Q · filed 2016-10-28 |
| 2016-06-30 | $171.00M 10-Q · filed 2016-07-22 |
| 2016-03-31 | $159.00M 10-Q · filed 2016-04-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |